(Q70087567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

F Schlicht

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

C Staiger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J de Vries

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

U Gundert-Remy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

R Hildebrandt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

N S Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

E Weber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

97-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00635715

8 October 2019

exact match

0 references

cites work

Tissue binding of drugs

1 reference

12 December 2020

Sulfinpyrazone kinetics after intravenous and oral administration

1 reference

12 December 2020

Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine

1 reference

12 December 2020

The role of the gut flora in the reduction of sulphinpyrazone in the rat

1 reference

12 December 2020

Statistical moments in pharmacokinetics.

1 reference

12 December 2020

Effect of plasma protein and tissue binding on the biologic half-life of drugs

1 reference

12 December 2020

Induction of drug metabolizing enzymes by sulfinpyrazone

1 reference

12 December 2020

Prolonged inhibition of ex vivo sodium arachidonate-induced platelet aggregation and malondialdehyde (MDA) production by sulphinpyrazone (Anturan) in man

1 reference

12 December 2020

Observations on G-25671, a phenylbutazone analogue (4-phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione)

1 reference

12 December 2020

Plasma levels of sulfinpyrazone and of two of its metabolites after a single dose and during the steady state

1 reference

12 December 2020

Drug metabolite kinetics

1 reference

12 December 2020

Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.

1 reference

12 December 2020

Commentary: a physiological approach to hepatic drug clearance

1 reference

12 December 2020

Species differences in the disposition and metabolism of sulfinpyrazone

1 reference

12 December 2020

Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial

1 reference

12 December 2020

Two new metabolites of sulfinpyrazone in the rabbit: A possible cause of the prolonged effect

1 reference

12 December 2020

Excretion of Sulfinpyrazone in the Rat

1 reference

12 December 2020

Effect of sulfinpyrazone on platelet survival time in patients with transient cerebral ischemic attacks

1 reference

12 December 2020

Kinetics and metabolism of sulfinpyrazone

1 reference

12 December 2020

Influence of Gut Microflora on Bioavailability

1 reference

12 December 2020

Analysis of sulfinpyrazone and its metabolites in human plasma and urine by high-performance liquid chromatography

1 reference

12 December 2020

High-performance liquid chromatographic analysis of the sulfide metabolite of sulfinpyrazone in plasma

1 reference

12 December 2020

New metabolites of sulfinpyrazone in man.

1 reference

12 December 2020

In vivo evaluation of Michaelis-Menten constants of hepatic drug-eliminating systems

1 reference

12 December 2020

Simultaneous determination of sulfinpyrazone and four of its metabolites by high-performance liquid chromatography

1 reference

12 December 2020

Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol

1 reference

12 December 2020

Noncompartmental Determination of the Steady‐State Volume of Distribution

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00635715

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3987792%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference